However, the Azar proposal is misguided in that, despite his assertions otherwise, enacting it will have a negative effect on pharmaceutical R&D in areas of serious medical need.
Azar’s Plan To Tie U.S. Drug Prices To Foreign Ones Will Impact Investments In R&D
